Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Temporal Genomics Mechanisms Underlying Disease and Aging
Authors not listed
Penn State University · 2018
Abstract
Given the salient role of early-life adversity and the resulting biological embedding in disease risk, there is a critical need to understand the mechanisms operating at multiple levels of analysis in order to promote effective clinical treatments and intervention efforts for survivors. An example for such an effort could be to utilize models of dynamic cellular markers as individual-level factors to account for variation in intervention response and clinical outcomes. Results of this study will lead to new knowledge about specific gene expression pathways in response to stress, and whether the response is moderated by previous exposure to early adversity, shorter telomere(definition) length (a marker of cellular aging) and self-report mental-health measures. Thus, the long-term effects of this study will advance our understanding on stress-related transcriptomic changes that play a downstream role in disease susceptibility and accelerated aging, with the goal of targeting specific pathways and genes for potential intervention studies and pharmacological treatments to reverse the effects of exposure to early adversity. For example, considering high failure rates for depression treatments, and in order to tailor individual interventions, identifying objective changes in stress-induced gene expression may help to predict intervention efficacy in clinical and non-clinical settings, as seen, for example, in breast and leukemia cancers. Thus, findings will have a range of impacts for basic science, intervention studies and clinical practice that will influence treatments to match the specific cellular processes operating within an individual.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Anonymous. (2018). Temporal Genomics Mechanisms Underlying Disease and Aging. <em>Penn State University</em>. https://clinicaltrials.gov/study/NCT03637751
Vancouver
Anonymous. Temporal Genomics Mechanisms Underlying Disease and Aging. Penn State University. 2018.
BibTeX
@misc{anon2018Tempor,
title = {Temporal Genomics Mechanisms Underlying Disease and Aging},
author = {Anonymous},
journal = {Penn State University},
year = {2018},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Redox Biology 2019
Open access · CC-BY
On the epigenetic role of guanosine oxidation
Brazilian Journal of Medical and Biological Research 2017
Open access · CC-BY
Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A
Nature Communications 2019
Open access · CC-BY
Prioritizing Parkinson’s disease genes using population-scale transcriptomic data
Molecular Aspects of Medicine 2011
Citation only
Hormesis, cellular stress response and vitagenes as critical determinants in aging and longevity
University of California, San Francisco 2006
Open access · US-GOV
Effects of Stress Reduction on Eating, Fat Distribution, and Cell Aging Among Overweight Women
Methods in molecular biology 2009
Citation only